Conference - Events
Featured Events
After a turbulent year in the gene therapy field, the 3rd Gene Therapy Potency Assay Summit returns at a time when drug developers are increasingly recognizing that it is business-critical to have a robust potency assay to support clinical and commercial progress.
For potency assay experts, there is no other meeting offering in-depth technical discussions with a genuine expert community who are uniting to discuss essential sticking points like phase-appropriate assay development, methodology progress, reducing lot-to-lot variability, and aligning to changing regulatory guidelines.
Engage with analytical leads to discuss shared pain points, new technologies enabling improved predictability, and hear perspectives from those who have been through IND-enabling studies and all the way to commer…
As the autoimmune wave breathes financial life back into the allogeneic space, and a growing number of oncology pipelines entering the clinic, it is now business critical that allogeneic drug developers prove the potential of the off-the-shelf approach to enable reduced cost of goods and greater access for patients.
As the must-attend meeting for the allogeneic community, the 7th Annual Allogeneic Cell Therapies Summit will address the critical challenges in optimizing complex gene engineering, ensuring safety and potency of off-the-shelf cell therapies to accelerate your path to clinical and commercial success.
Spanning preclinical development through to manufacturing and process development, brainstorm with industry pioneers the best approaches for developing preclinical assays, targetin…
Events
The 29th European Nephrology Conference, will be held on May 26-27, 2025, in the historic city of Rome, Italy. This premier event in nephrology will bring together leading experts, researchers, and clinicians from across the globe to advance the understanding and treatment of kidney diseases. The conference will feature an extensive program designed to address the latest advancements and challenges in nephrology. Attendees can look forward to a diverse range of sessions, including keynote lectures by distinguished speakers, interactive panel discussions, and specialized workshops. Topics will cover cutting-edge research and clinical practices in areas such as chronic kidney disease, renal transplantation, dialysis therapies, and precision medicine. Key highlights o…
The i-Cancer Congress is a premier international event scheduled to take place in Toronto, Canada on May 26-27, 2025. This congress brings together leading experts, researchers, healthcare professionals, and industry leaders in the field of oncology to discuss and share the latest advancements in cancer research, treatment, and care. The i-Cancer Congress offers an unparalleled opportunity to stay updated on the latest trends and developments in oncology. Attendees will benefit from educational sessions, networking opportunities, and exposure to innovative solutions and technologies shaping the future of cancer treatment. This event is designed to enhance knowledge, foster collaboration, and inspire new approaches to combat cancer.
Event Highlights
Cutting-Edge Research Presentations: Eng…
Accelerate Your Ophthalmic Development with Deep Learning Systems and Sophisticated AI Imaging Technologies...
With state-of-the-art AI-assisted technology making retinal imaging 100 times faster, the rapid advancement of technology in ophthalmology, coupled with the strong unmet need for more drugs for retinal diseases, highlights the urgency of continued focus and progress in this space. This need is emphasized by Merck's recent $3 billion acquisition of EyeBio. In light of this, as we move into 2025 and beyond, there is a real need to re-unite the retinal imaging biomarkers and endpoints community to align efforts and propel the field to new heights.
The 3rd Annual Retinal Imaging Biomarkers and Endpoints Summit is addressing this need head on by uniting clinical scientists, imaging sci…
The Dermatology Drug Development Summit Europe returns for its 6th year as the premier industry forum dedicated to advancing next-generation immunodermatology therapies. With regulatory breakthroughs reshaping the landscape-such as Eli Lilly’s IL-13 inhibitor and LEO Pharma’s topical JAK-I-2024 was a pivotal year for the industry to accelerate innovation.
Join 80+ senior leaders from Sanofi, Alys Pharmaceuticals, Moonlake Immunotherapeutics, and more to ensure 2025 breaks new records for the industry!
Get stuck into topics such as:
- Explore novel clinical and preclinical candidate data to produce best-in-class drugs for diverse indications- Understand contemporary indication expansion strategies to maximise the value of your pipeline and diversify your immuno-inflammatory portfolio- Colla…
After a turbulent year in the gene therapy field, the 3rd Gene Therapy Potency Assay Summit returns at a time when drug developers are increasingly recognizing that it is business-critical to have a robust potency assay to support clinical and commercial progress.
For potency assay experts, there is no other meeting offering in-depth technical discussions with a genuine expert community who are uniting to discuss essential sticking points like phase-appropriate assay development, methodology progress, reducing lot-to-lot variability, and aligning to changing regulatory guidelines.
Engage with analytical leads to discuss shared pain points, new technologies enabling improved predictability, and hear perspectives from those who have been through IND-enabling studies and all the way to commer…
With CSL Seqirus and Arcturus Therapeutics successfully developing the first approved self-amplifying RNA vaccine, the field of next generation RNAs celebrates the potential of circular and self-amplifying RNAs to provide improved stability, durability, longevity and efficacy for treating a wide array of diseases.
This May, the 4th Circular and Self-Amplifying RNA Therapeutics Summit (previously known as 'Next Generation RNA Therapeutics Summit) is landing back in Boston, as the unique opportunity to unite with leading stakeholders in the next generation RNA field, including the likes of Sail Biomedicines, Merck, Novo Nordisk, Replicate Bioscience and more. This is your one-stop shop to hear the latest approaches and applications of circular and self-amplifying RNA therapeutics and vaccine…
Welcome to the 5th Edition of the Chemistry World Conference (Chemistry 2025), set in the historic city of Rome, Italy, from June 2-4, 2025. This hybrid event, themed "Chemistry: Innovations, Applications, and Sustainability," offers both onsite and virtual participation.Chemistry Conferences 2025 unites researchers, academics, industry experts, and enthusiasts globally. Attendees will delve into topics such as analytical chemistry, medicinal chemistry, nanoscience, and structural chemistry. The Medicinal Chemistry Conferences 2025 encourages interdisciplinary learning with discussions on catalysis, biochemistry, and environmental sustainability.Engage in presentations, workshops, and panel discussions on computer-aided drug design, advancements in organic synthesis, and chemistry's impact…
Welcome to the 4th In Vivo Cell Engineering and Gene Editing Summit, the premier event dedicated to enhancing the next frontier of in vivo cell and gene approaches from research to clinic. This summit provides you with exclusive insights into the latest IND enabling data, regulatory and inter-governmental processes and requirements, best-in-class delivery technologies, cutting-edge innovations in editing and engineering and insights into effective clinical trial design from industry leaders including Capstan Therapeutics, Editas Medicine, Carisma Therapeutics, AbbVie, Intellia Therapeutics, Umoja Biopharma and many more!
The in vivo approach is revolutionizing the cell and gene space. These ground-breaking technologies promise more efficient, accessible and cost-effective therapies and pav…
With tightening budgets and increasing pressure to de-risk R AND D, pharma and biotech are shifting their focus toward smarter, more efficient drug design. Companies are investing more in enabling technologies-from computational modeling and AI-driven predictions to structural biology techniques like Cryo-EM, NMR, and X-ray crystallography-to improve rational drug design and enhance decision-making early in discovery.
While AI-powered structure prediction is transforming the landscape-recognized by the 2024 Nobel Prize for Google DeepMind’s AlphaFold2- its true impact depends on experimental validation. The ability to integrate computational insights with high-resolution structural data is now essential for unlocking complex targets and accelerating drug discovery.
Cryo-EM continues to pus…
The 3rd International Alzheimer's Disease & Dementia Conference (Dementia 2025) will be held from June 5-7, 2025, in the historic city of Rome, Italy. Under the theme "Beyond Boundaries: Global Advances in Alzheimer's and Dementia Care," this conference will explore cutting-edge research and innovative approaches in the field of dementia care.
Alzheimer's Disease Conferences 2025 offers a hybrid format, combining onsite and online participation to accommodate a global audience. This inclusive setup ensures that experts and participants from around the world can engage in meaningful discussions, share groundbreaking research, and collaborate on advancing dementia care.
Join Dementia Conferences 2025 in Rome for this pivotal event to gain invaluable insights, connect with leading profess…
05-Jun-2025 - 07-Jun-2025
The 11th Edition of the International Conference on Neurology and Neurological Disorders (Neurology 2025) is set to take place from June 5-7, 2025, in the captivating city of Rome, Italy. This hybrid event, hosted by Magnus Group, provides an exceptional opportunity for both on-site and virtual participation, catering to professionals across the globe.
With the theme "Frontiers of Neurology: Bridging Science, Medicine, and Technology," Neurology Conferences will explore the latest advancements and future directions in neurology. The conference aims to unite experts, researchers, and practitioners to discuss breakthroughs in neurological science, innovative medical treatments, and technological integrations in patient care. Attendees will benefit from a diverse range of sessions, including…
As regulators and payers increasingly elevate the importance of RWE in submission requirements and with an explosion of datasets opening up in parallel with advancing AI, deep learning, and large language models transforming big data analysis, it has never been more critical to keep up with the matrix of country-specific regulatory nuances and industry case studies in optimizing integrated evidence plans, bullet-proofing data quality, and navigating vendor selection.
The 2nd IMPACCT Real World Evidence Summit Europe is the only industry meeting dedicated to uniting experts in RWE and Evidence Generation to consolidate, innovate and apply RWE across the drug development lifecycle, from external control arms to reimbursement.
With a tight focus on leveraging AI for both efficiency gains and…
Introducing the Vendor Management and Outsourcing for Clinical Trials Summit, built with the industry to the needs of vendor management, outsourcing and clinical operations professionals.
Vendor management processes are crucial for ensuring compliance, quality, and timely delivery at every stage, serving as the backbone of successful clinical trials. Acknowledging the transformative impact, the industry is prioritizing the optimization of these intricate processes, making significant investments to enhance key functions, improve performance, and maintain a competitive edge. Despite this professionals managing ancillary lab vendors and CROs lack a dedicated forum to address their unique challenges, until now...
Join us and uncover exclusive strategies to enhance onboarding and standardizati…
As the autoimmune wave breathes financial life back into the allogeneic space, and a growing number of oncology pipelines entering the clinic, it is now business critical that allogeneic drug developers prove the potential of the off-the-shelf approach to enable reduced cost of goods and greater access for patients.
As the must-attend meeting for the allogeneic community, the 7th Annual Allogeneic Cell Therapies Summit will address the critical challenges in optimizing complex gene engineering, ensuring safety and potency of off-the-shelf cell therapies to accelerate your path to clinical and commercial success.
Spanning preclinical development through to manufacturing and process development, brainstorm with industry pioneers the best approaches for developing preclinical assays, targetin…
The Cardio-Renal-Metabolic (CVRM) Innovation Pharma Partnering Summit is a hyper-aligned business development forum for companies addressing pathologies driving cardiovascular, kidney, and metabolic diseases.
This exclusive summit brings together over 80 on-scope and in-strategy companies, providing targeted face-to-face networking, and opportunities to validate biotech innovations against the interests of pharma and qualified investors.
Designed to maximize your success, the scientifically focused environment of the summit guarantees a minimum of 25% meeting acceptance rates and at least four productive meetings with strong follow-up potential. Increase your meeting success rates and build meaningful collaborations in this exclusive setting.
"The opportunity had gone cold since the initia…
The Pharma Market Research Conference West (June 11-12, 2025, South San Francisco) is the premier gathering of senior-level pharmaceutical, biotechnology, medical device, and diagnostics executives in market research. This prestigious event brings together the industry’s top thought leaders and creates an environment of new ideas, relationships and perspectives.
The event is unlike any other conference in the Bay Area. It’s immersive, interactive and focused on giving you and your colleagues the methodologies to deal with the new challenges and opportunities facing the industry.
The Pharma Market Research Conference is the best and largest industry assembly of market research executives in pharma, biotech, medical devices & diagnostics for 15+ years.
For more information, please go to…
16th Annual Clinical Trials Summit 2025
“Mastering Clinical Trials: A Comprehensive Guide to Success”
11th & 12th June 2025, Kohinoor Mumbai - India
16th Annual Clinical Trials Summit 2025 will provide a platform to discuss on the futuristic advancements in Clinical Trials and clinical research. This multidisciplinary program involves broad participation of people from Clinical Trials community who are focused on learning more about clinical research, Clinical Trials planning & management. This event opens discussion of timely topics of mutual theoretical and practical interest for clinical trial investigators who are developing new drugs and biologics.
Please contact Email - kavitha@virtueinsight.co.in or Call - M: +91 9361957193
We have more opportunities for Exhibiti…
The marcus evans 17th Edition Strategic Alliance Management for Pharma conference taking place on 12-13 June, 2025, in Boston, MA, will bring together industry leaders and innovators to explore actionable strategies for licensing, conflict resolution, cultural integration, digital transformation, and navigating cross-border collaborations. Whether you're driving growth through strategic alliances, managing M&A partnerships, or leading global teams, this event delivers cutting-edge insights to elevate your alliances and maximize impact.
Key Topics include:
Generate Win-Win Opportunities and Maximise the Partnership Value
Alliance Leadership and Stakeholder Management - or why “Influence is your Superpower”
What are the strategic ‘value buckets’ of an alliance manager?
Navigate Complexi…
Welcome to the Inaugural Dark Genome Target Discovery and Development Summit
The Dawn of the Dark Genome Has Arrived...
Significant technological advances in computational biology, next-gen sequencing, -omics platforms and AI have unlocked the transformative potential of drug discovery in the dark genome, resulting in investment and partnerships totalling over $1.5 billion in the past 6 months alone.
Designed to bring together the growing community of pioneers, the inaugural Dark Genome Target Discovery and Development Summit is the first industry-focused forum to decipher the mysteries of non-coding DNA and RNA to reveal its role in disease, while uncovering and validating novel targets across oncology, neuroscience, aging, heart disease and beyond!
Featuring a star-studded speaker line-u…
Lipid-based nanoparticles are evolving-faster, safer and more precise than ever. With traditional LNPs struggling to reach tissues beyond the liver, the industry is doubling down on next generation technologies for extra-hepatic. In 2024 alone, Novo Nordisk invested $600M in NanoVation to push genetic medicines further, while Nanite and Saliogen joined forces to pioneer non-viral, lung-targeting nanoparticles.
Formerly known as the Next Gen Lipid-Based Nanoparticle Delivery Summit, the summit is the only industry-dedicated event laser-focused on extrahepatic targeting, delivery efficiency and scalable manufacturing for mRNA, siRNA, DNA and gene therapies.
Join 80+ delivery experts, CXOs and leading scientists from AstraZeneca, Novo Nordisk, Takeda, Orbital Therapeutics and more for three j…
